The pharmaceutical industry is ever thirsty to satisfy patient’s therapeutical needs and apart from active ingredients, inactive excipients play a major role in formulation development. Pharmaceutical excipients are substances other than the Pharmacologically active drug or Prodrug which are included in the manufacturing process or are contained in a finished pharmaceutical product dosage form
3. Application in pharmaceutical formulation:
Used as a semipermeable coating on tablets.
Used in transdermal drug delivery systems.
Highly absorbent and resistant to moderate temperature.
They don’t shrink or wrinkle.
Stability and storage conditions:
Stable if stored in a well-closed container in a cool, dry place .
Incompatibilities:
Incompatible with strongly acidic or alkaline substances.
5. Applications in Pharmaceutical Formulation:
Used as an enteric film coating material.
Used as a matrix binder for tablets and capsules.
Commonly applied to solid-dosage forms.
Stability and Storage Conditions
Stable if stored in a well-closed container in a cool, dry place.
Incompatibilities
Incompatible with ferrous surface, ferric chloride, sodium citrate.
7. Applications in Pharmaceutical Formulation:
Naturally occurring materials generally used as substitute for tragacanth.
Used as a binder, thickening agent, and stabilizing agent in the cosmetics and
food industry.
Stability and Storage Conditions
Stored in a well-closed container in a cool, dry place.
Ceratonia loses not more than 15% of its weight on drying.
Incompatibilities
The viscosity of xanthan gum solutions is increased in the presence of ceratonia.
9. Applications in Pharmaceutical Formulation:
Used as a stiffening agent in creams and ointments.
Emulsion stabilizer, viscosity control agent.
Thickener in pharmaceutical protective, topical, and vaginal creams.
Used in cosmetics and personal care products.
Stability and Storage Conditions
Stored in well-closed containers in a cool, dry, well-ventilated
place, away from extreme heat and strong oxidizing agents.
Incompatibilities
Incompatible with strong oxidizing agents.
11. Applications in Pharmaceutical Formulation:
Used in cosmetics and topical pharmaceutical preparations.
Used in the preparation of non aqueous creams sticks, and in non lathering
shaving creams.
Stability and Storage Conditions
Stable under normal storage conditions.
Stored in a well-closed container in a cool, dry place.
Incompatibilities
Strong oxidizing agents and metal salts.
13. Applications in Pharmaceutical Formulation:
Quaternary ammonium compound that is used in cosmetics and pharmaceutical
formulations as an antimicrobial preservative.
Used as a catholic surfactant.
Stability and Storage Conditions
Stable in the dry state, and also in aqueous solution at ambient temperatures.
Bulk material should be stored in a well-closed container in a cool, dry place.
Incompatibilities
Incompatible with soaps, anionic surfactants, high concentrations of non-ionic
surfactants. Aqueous solutions react with metals.
15. Applications in Pharmaceutical Formulation:
Used in cosmetics and pharmaceutical formulations such as suppositories,
modified-release solid dosage forms, emulsions, lotions, creams.
Used for its water absorption properties in water-in-oil emulsions and ointments.
Stability and Storage Conditions
Stable in the presence of acids, alkalis, light, and air.
It does not become rancid.
Stored in a well-closed container in a cool, dry place.
Incompatibilities
Incompatible with strong oxidizing agents
17. Applications in Pharmaceutical Formulation:
Used therapeutically as an antiseptic agent.
Mouthwashes containing cetylpyridinium chloride have been shown to inhibit
plaque formation.
Stability and Storage Conditions
Stable under normal conditions. It should be stored in well-closed containers.
Incompatibilities
Incompatible with strong oxidizing agents and bases.
19. Applications in Pharmaceutical Formulation:
Used in cosmetics and is under investigation for use in a number of
pharmaceutical formulations.
Stability and Storage Conditions
Stable material at room temperature, although it is hygroscopic after drying.
Stored in a tightly closed container in a cool, dry place.
Incompatibilities
Incompatible with strong oxidizing agents
20. Final weight of tablet=300 mg
API (Ciprofloxacin)=150 mg
Excipients=150 mg
Ingredients
Names
Functions Amounts (mg) Amounts (%)
Ciprofloxacin API 150 mg
Ceratonia Tablet binder 12 mg 4%
Microcrystalline Disintegrates 30 mg 10%
Na Stearate Lubricants 3 mg 1%
Cellulose acetate
phthalate
Coating agents 4.5 mg 1.5%
Cellulose acetate Diluent 100.5 mg 33.5%
Formulation of Tablet